|
Participant number
|
Gender and approximate age of participants
|
Duration of prescribed medication at time of trial entry
|
Centre
|
Trial participation decision
|
|---|
|
1
|
Female early 40 s
|
8 years
|
A
|
Randomised
|
|
2
|
Female early 50 s
|
5 years
|
A
|
Declined
|
|
3
|
Female mid 40 s
|
10-13 years
|
A
|
Randomised
|
|
4
|
Male mid 60 s
|
6 years
|
A
|
Randomised
|
|
5
|
Male early 20 s
|
2-3 years
|
B
|
Preference medical
|
|
6
|
Male early 30 s
|
4-5 years
|
B
|
Randomised
|
|
7
|
Male early 50 s
|
18 months
|
B
|
Preference medical
|
|
8
|
Female early 60 s
|
18 months -2 years
|
A
|
Declined
|
|
9*
|
Female early 20 s
|
12 -18 months
|
B
|
Randomised
|
|
10
|
Male late 30 s
|
1 year
|
A
|
Randomised
|
|
11
|
Female mid 50 s
|
8 years
|
A
|
Randomised
|
|
12
|
Male early 50 s
|
1 year
|
B
|
Randomised
|
|
13
|
Male mid 40 s
|
1 year
|
B
|
Randomised
|
|
14
|
Male late 40 s
|
18 months - 2 years
|
A
|
Randomised
|
- *Participant 9 initially consented to joining the qualitative study and to participate in the REFLUX trial. However, she did not respond to any subsequent communications and so contributed no data to the study.
